Investment Intern Life Sciences - Dementia Team - Amsterdam

Investment Intern – Life Sciences - Dementia Team - Amsterdam 

EQT Life Sciences is seeking a curious and analytically minded Investment Intern to join our Amsterdam-based neuroscience investment team for a period of six months. This is a hands-on opportunity to contribute to neuroscience investing at one of Europe's most experienced specialist investors, gaining meaningful exposure across the full investment cycle. 

About the Team 

EQT Life Sciences, formerly LSP, has spent over 30 years backing companies at the frontier of human health. We invest in therapeutics, medical devices, diagnostics and healthtech globally, and have raised around €3.5 billion across 12 private funds and three investment strategies. we have backed 150 companies and brought over 100 medications and technologies on the market to patients. Our team brings together professionals from medicine, science and industry, united by a shared belief that the right capital, paired with deep scientific expertise, can genuinely change outcomes for patients. One of these strategies exclusively invests in therapeutics, diagnostics and technologies working to prevent, diagnose and treat dementia and other neurodegenerative diseases, among the greatest unmet needs in medicine today. 

About the Role 

As an Investment Intern, you will work closely alongside our investment professionals in Amsterdam, contributing to real work across the full breadth of our activity, from identifying new opportunities to supporting due diligence and engaging with portfolio companies. This role is designed to give you meaningful, practical exposure to how life sciences investment decisions are made. 

• Screen and assess new investment opportunities in dementia and neurodegeneration, spanning therapeutics, diagnostics, medical devices and enabling technologies 

• Contribute to scientific, clinical and commercial due diligence on prospective investments 

• Conduct market research, competitive analysis and reviews of the scientific literature 

• Help prepare investment materials and internal analyses to support the team's decision-making 

• Collaborate closely with senior investment professionals on live transactions and portfolio work 

• Gain direct exposure to portfolio companies operating at the frontier of neuroscience research 

About You 

You are intellectually curious, analytically grounded and genuinely excited about the intersection of science and investment. You communicate complex ideas clearly, take ownership of your work and contribute thoughtfully in a collaborative setting. 

What you'll bring (must-have): 

• A Master's degree in a life sciences discipline, such as neuroscience , medicine, pharmacy, chemistry, biology or a related field 

• At least two years of relevant experience beyond your undergraduate studies, whether through professional work, a PhD programme or advanced postgraduate study 

• Experience reading and critically appraising clinical or scientific literature 

• A strong interest in scientific innovation and how novel discoveries translate into medicines or medical technologies 

• Proven ability to synthesise complex scientific information and present it clearly, both in writing and in conversation 

• Fluency in English, written and spoken 

• A proactive, collaborative working style with the ability to take ownership and manage your own workload 

Nice to have: 

• Familiarity with the life sciences investment landscape or prior exposure to a healthcare or biotech environment
   


• A background or demonstrable interest in neuroscience, neurology or neurodegenerative diseases 
  
  


• Additional European language skills 

What We Offer 

• Practical, meaningful exposure to life sciences investing at one of Europe's leading specialist firms 

• Close mentorship from investment professionals with deep backgrounds in medicine, science and industry 

• Broad experience across neuroscience, from therapeutics and diagnostics to digital and enabling technologies, including engagement with companies at the frontier of their fields 

• An international, intellectually stimulating and collaborative environment, supported by the wider EQT platform 

• A flexible start date and an internship duration of five to nine months 

Inclusion at EQT

Our vision for EQT employees is to build high performing & engaged teams. Our competitive edge comes from fostering an environment where every individual feels valued, empowered, and motivated to drive business impact. Our commitment to inclusion is not just about fairness; We understand and believe that being a great place to work drives the best performance.At EQT, inclusion is a business imperative and it's embedded into our talent strategy, decision-making, and culture to ensure that every individual and team operates at their full potential. By doing so, we unlock better collaboration, stronger innovation, and superior investment outcomes.

About EQT

EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of over three decades of developing companies across multiple geographies, sectors and strategies. EQT has investment strategies covering all phases of a business’ development, from start-up to maturity. EQT has EUR ‌​​270 billion in total assets under management (EUR ‌​​‌141 billion in fee-generating assets under management), within two business segments – Private Capital and Real Assets.

With its roots in the Wallenberg family’s entrepreneurial mindset and philosophy of long-term ownership, EQT is guided by a set of strong values and a distinct corporate culture. EQT manages and advises funds and vehicles that invest across the world with the mission to future-proof companies, generate attractive returns and make a positive impact with everything EQT does. EQT has offices in more than 25 countries across Europe, Asia and the Americas and has more than 1,900 employees.

More info: www.eqtgroup.com
Follow EQT on LinkedIn, X, YouTube and Instagram